Managing Pediatric Seizure Cases in the OPD

1. First step: Confirm it's actually a seizure

2. Triage by red flags - decide OPD vs ED referral

• Seizure still ongoing or lasted >5 minutes (impending status epilepticus)
• Age <6 months
• Focal neurological deficits, or not returning to baseline mental status
• Signs of meningitis/encephalitis (bulging fontanelle, neck stiffness, severe lethargy, petechial rash)
• Recent head trauma, VP shunt, suspected toxin ingestion
• Multiple seizures within 24 hours (complex febrile seizure) with ill appearance
• Underlying immunocompromise or unimmunized status with fever

3. Febrile seizures (most common OPD presentation, 2-5% of children 6mo-6yr)

• Management: Identify and treat the fever source (urinalysis/culture as indicated). No EEG, no neuroimaging, no routine bloodwork, and no antiseizure medication are needed in a well-appearing, neurologically normal, fully immunized child - Harriet Lane Handbook, Tintinalli's Emergency Medicine.
• Lumbar puncture is only considered if: signs of meningitis are present, the child is 6-12 months old and unimmunized/unknown immunization status for Hib or S. pneumoniae, or the child was pretreated with antibiotics (which can mask meningitis).
• Parent counseling: recurrence risk is ~30% (>12 months old) to 50% (<12 months old); risk of later epilepsy is only about 1% (same as general population), rising to ~7% with risk factors (family history of seizures, complex/multiple febrile seizures, first seizure before age 12 months, developmental delay, focal features).

• Still generally does not need routine bloodwork/LP/imaging in the absence of other clinical signs, though threshold for LP and closer observation is lower. Children with prolonged seizure who appear ill need evaluation for serious bacterial infection (blood + CSF), without delaying antibiotics.

4. First unprovoked (afebrile) seizure

• Referral for outpatient EEG and possibly MRI (non-emergent) to characterize seizure type/etiology
• Pediatric neurology referral, especially before starting any antiepileptic drug
• Most guidelines do not recommend starting AEDs after a single unprovoked seizure in an otherwise well child - the decision is individualized with neurology input based on EEG findings, imaging, and recurrence risk.

5. If a seizure is actively ongoing when the child is in your OPD

• ABCs, position to protect airway, oxygen, glucose check
• Benzodiazepine as first-line if seizure ongoing >5 minutes (e.g., buccal/intranasal midazolam or rectal diazepam if no IV access) - delay beyond 10 minutes in starting benzodiazepines is associated with worse outcomes
• Arrange emergency transport - do not attempt to manage prolonged/refractory status epilepticus in a standard OPD setting; second-line agents (levetiracetam, fosphenytoin, valproate) and airway support are ED/inpatient level care.

6. Follow-up and safety counseling for all OPD seizure visits

• Seizure first-aid education for parents/caregivers (positioning, timing, when to call emergency services - e.g., seizure >5 min or repeated seizures without recovery)
• Antipyretic use for comfort during febrile illness (does NOT prevent febrile seizure recurrence, but reduces fever discomfort)
• Clear return precautions and scheduled neurology follow-up if this was a first seizure, complex febrile seizure, or if EEG/imaging was ordered

Recent Clinical Guidelines on Pediatric Seizure Management

1. Febrile Seizures

2. First Unprovoked (Afebrile) Seizure

3. Status Epilepticus - Emergency Management (most actively updated area)

• Canadian Paediatric Society position statement (McKenzie et al., Paediatrics & Child Health, 2021, PMID: 33552322) - the most complete recent CSE algorithm for children/infants >1 month, replacing the 2011 statement, with an updated stepwise medication table (benzodiazepine first-line, then a second-line ASM, then anesthetic infusions for refractory SE).
• 2025 systematic review/meta-analysis of midazolam vs. lorazepam in pediatric status epilepticus (PMID: 40876407): across 4 RCTs (326 patients), midazolam was non-inferior to lorazepam for seizure termination and safety; intranasal midazolam showed faster administration and quicker seizure control on arrival, supporting its practical use when IV access is delayed.
• STEPSS severity score validation (2025 meta-analysis, PMID: 40305995): the Status Epilepticus in Pediatric patients Severity Score showed strong predictive accuracy for outcomes (AUC 0.85), supporting its use for risk-stratifying children with SE.
• A 2024 national adaptation effort in Egypt (PMID: 38838593) illustrates how the American Epilepsy Society, Italian League Against Epilepsy, and Neurocritical Care Society SE guidelines are being locally adapted worldwide - useful if you need the underlying source guidelines.

4. Chronic Epilepsy Diagnosis, Classification, and Long-Term Management

• NICE NG217 - Epilepsies in children, young people and adults (originally 2022, updated January 2025) remains the most comprehensive UK-based guideline spanning diagnosis, first-line ASM selection (lamotrigine now first-line for focal epilepsy across ages per 2025 update), referral pathways, and transition to adult care.
• ILAE 2025 updated seizure classification (Beniczky, Trinka, Wirrell et al., Epilepsia 2025 / practical guide Epileptic Disorders 2025, PMID: 41081650) - revises focal/generalized/unknown/unclassified categorization, relevant for accurate diagnosis coding and treatment selection.
• ILAE Task Force guideline for neonatal seizures (2023) - separate from seizures beyond the neonatal period, covering phenobarbital first-line therapy and EEG monitoring criteria in neonates.
• Cochrane systematic review (2025) on service delivery, behavioral, and self-management interventions for children with epilepsy (PMID: 41123096) - evaluates structured care programs, seizure action plans, and self-management education; found modest quality evidence but supports formalized seizure action plans (echoed by the AAP's current "Managing Pediatric Epilepsy" patient-care resource, which recommends every child have a written Seizure Action Plan for caregivers/schools).
• ILAE Psychiatric Pediatric Issues Task Force consensus (2024, PMID: 39320421) - recommendations for screening/managing anxiety and depression comorbid with pediatric epilepsy.

Practical takeaway for OPD practice

Topic Breakdown

1. Definitions & Classification - seizure vs. epilepsy vs. epileptic syndrome; ILAE classification (focal, generalized, unknown onset)
2. Etiology by age group - neonatal seizures, infantile, childhood, adolescent causes
3. Febrile Seizures - simple vs. complex, workup, prognosis
4. Common Pediatric Epilepsy Syndromes - infantile spasms/West syndrome, childhood absence epilepsy, BECTS (benign rolandic epilepsy), Lennox-Gastaut syndrome, juvenile myoclonic epilepsy
5. Diagnostic Evaluation - history/exam, EEG, neuroimaging (MRI/CT), labs, genetic/metabolic workup
6. Status Epilepticus - definition, emergency stepwise management
7. Antiepileptic Drug Therapy - first-line agents by seizure/syndrome type, side effects, monitoring
8. Non-pharmacologic Therapy - ketogenic diet, vagal nerve stimulation, epilepsy surgery
9. Differential Diagnosis - non-epileptic paroxysmal events (breath-holding spells, syncope, tics, pseudoseizures)
10. Prognosis & Long-term Management - recurrence risk, discontinuing AEDs, comorbidities (developmental, psychiatric), safety counseling

Brief Overview